HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Steven A Middleton Selected Research

JNJ-7706621

10/2006Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor.
10/2005The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Steven A Middleton Research Topics

Disease

10Neoplasms (Cancer)
07/2012 - 09/2004
5Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
01/2008 - 03/2007
5Lower Urinary Tract Symptoms
01/2008 - 03/2007
2Neoplasm Metastasis (Metastasis)
02/2007 - 09/2004
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2016
1Neuroblastoma
04/2015
1Liposarcoma
11/2012
1Carcinoma (Carcinomatosis)
10/2006
1Retinoblastoma (Glioblastoma, Retinal)
10/2005
1Pain (Aches)
03/2005

Drug/Important Bio-Agent (IBA)

5Phosphotransferases (Kinase)IBA
02/2008 - 09/2004
4alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA
01/2008 - 03/2007
4Adrenergic Antagonists (Antiadrenergic Agents)IBA
01/2008 - 06/2007
3Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
07/2005 - 09/2004
2RG7388IBA
01/2016 - 04/2015
2Doxorubicin (Adriamycin)FDA LinkGeneric
04/2015 - 09/2004
2Peptides (Polypeptides)IBA
02/2007 - 03/2005
2Cyclin-Dependent Kinases (cdk Proteins)IBA
10/2006 - 10/2005
2JNJ-7706621IBA
10/2006 - 10/2005
2Aurora KinasesIBA
10/2006 - 10/2005
1Proto-Oncogene Proteins c-mdm2IBA
01/2016
1Topotecan (Hycamtin)FDA LinkGeneric
04/2015
1Cisplatin (Platino)FDA LinkGeneric
04/2015
1Busulfan (Busulfex)FDA Link
04/2015
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
04/2015
1Temozolomide (Temodar)FDA LinkGeneric
04/2015
1Biomarkers (Surrogate Marker)IBA
11/2012
1RG7112IBA
11/2012
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
07/2012
12,2- dimethyl- N- (6- oxo- 6,7- dihydro- 5H- dibenzo(b,d)azepin- 7- yl)- N'- (2,2,3,3,3- pentafluoropropyl)malonamideIBA
07/2012
1Tyrosine Kinase InhibitorsIBA
04/2009
1ErbB Receptors (EGF Receptor)IBA
04/2009
1pyrimidineIBA
04/2009
1JNJ 28871063IBA
02/2008
1Tyrosine (L-Tyrosine)FDA Link
02/2008
1benzocycloheptapyridineIBA
08/2007
1KisspeptinsIBA
02/2007
1LigandsIBA
02/2007
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
12/2005
1Aniline CompoundsIBA
12/2005
1Becaplermin (PDGF-BB)FDA Link
12/2005
1PDGF receptor tyrosine kinaseIBA
12/2005
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2005
1Pharmaceutical PreparationsIBA
10/2005
1CDC2 Protein Kinase (Protein p34cdc2)IBA
10/2005
1Amino AcidsFDA Link
03/2005
1NociceptinIBA
03/2005
1A 17 (A-17)IBA
03/2005
1Opioid Analgesics (Opioids)IBA
03/2005
14- (4- (1- Amino- 1- methylethyl)phenyl)- 2- (4- (2- morpholin- 4- yl- ethyl)phenylamino)pyrimidine- 5- carbonitrileIBA
09/2004
1Paclitaxel (Taxol)FDA LinkGeneric
09/2004
1Angiogenesis InhibitorsIBA
09/2004

Therapy/Procedure

2Drug Therapy (Chemotherapy)
04/2015 - 11/2012
2Therapeutics
04/2015 - 09/2004
1Aftercare (After-Treatment)
09/2004